Genetic Factors in Joint Pain and Osteoarthritis Risk

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on joint, cartilage, and pain genetics. Browse all Genetics & Joint Health education

Joint pain and osteoarthritis run in families for reasons that go beyond wear and tear. Twin studies estimate that 40 to 65 percent of osteoarthritis risk is heritable, depending on the joint. Your genes help set how your cartilage is built, how quickly it breaks down, how strongly your body inflames a stressed joint, and even how intensely your brain registers the resulting pain.

The short answer: several pathways, not one gene

There is no single "arthritis gene." Instead, osteoarthritis risk is polygenic — dozens of common variants each nudge the odds. The most studied cluster shapes cartilage structure and repair. A second cluster governs inflammation. A third shapes how you perceive pain itself, which is why two people with identical joint imaging can report very different discomfort.

GDF5: the cartilage and joint-shape gene

GDF5 (growth differentiation factor 5) is one of the most robustly replicated osteoarthritis genes worldwide. A common variant in its regulatory region, rs143383, lowers GDF5 expression in joint tissue. Because GDF5 guides how joints form and how cartilage maintains itself, the lower-expression version is associated with modestly higher risk of hip and knee osteoarthritis across many populations. It is a small effect on its own — a predisposition, not a diagnosis — but it illustrates how a single letter in your DNA can influence joint durability decades before symptoms appear.

COMT: why the same joint can hurt differently

Pain is a biological signal, and genetics shape its volume. COMT (catechol-O-methyltransferase) breaks down dopamine and norepinephrine, neurotransmitters involved in pain processing. The well-known Val158Met variant (rs4680) changes enzyme activity, and research links the lower-activity "Met" version to heightened pain sensitivity and a stronger pain response to inflammation. For joint health, COMT status helps explain why cartilage loss and reported pain are only loosely correlated — your pain-processing genetics are part of the equation.

Collagen and inflammation: COL2A1, MMP3, and IL1

Cartilage is mostly type II collagen, encoded by COL2A1; rare and common variants here affect cartilage integrity. MMP3 encodes an enzyme that degrades the cartilage matrix, and certain MMP3 variants are associated with faster progression once osteoarthritis begins. Variants in the IL1 gene cluster (including IL1B) can raise inflammatory signaling, tilting a stressed joint toward more swelling and breakdown. Vitamin D signaling adds another layer: the VDR (vitamin D receptor) gene shapes how well cartilage and bone respond to vitamin D, and some VDR variants have been associated with osteoarthritis progression in the knee and hip. Together these genes describe a build-versus-breakdown balance that differs from person to person, and it shifts across the lifespan as hormones, activity, and body composition change.

Your genes set the baseline — your habits move the dial

Genetics load the odds, but daily inputs are decisive. Excess body weight multiplies mechanical load on knees and hips and also raises systemic inflammation, compounding an unfavorable IL1 or MMP3 profile. Progressive strength training protects joints by stabilizing them. Adequate protein, vitamin D, and omega-3 intake support cartilage and dampen inflammation. None of these change your genotype, but they change how that genotype is expressed — which is where most of your real-world control lives.

Where pathway-level genetic insight fits

Understanding your baseline is the point. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across the biological systems that intersect with joint comfort, cartilage maintenance, inflammation, and pain signaling. It does not diagnose osteoarthritis or tell you what to take. It gives you pathway-level context — the kind of information you and a qualified provider can use to prioritize the lifestyle levers most likely to matter for your biology. As we say: PlexusDx tells you about your biology; it does not tell you what to put in your body.

Frequently Asked Questions About Joint Genetics

Is osteoarthritis inherited?

Partly. Twin and family studies estimate 40 to 65 percent of osteoarthritis risk is heritable, with the rest driven by age, joint injury, body weight, and activity. Genes such as GDF5 and COL2A1 raise baseline risk, but lifestyle and mechanical load determine much of whether and when symptoms appear.

Can a genetic test tell me if I will get arthritis?

No. Genetic insights describe predispositions across cartilage, inflammation, and pain pathways — not a diagnosis or a prediction of any disease. The Precision Peptide Genetic Test offers pathway-level context to discuss with a provider. Only a clinician can diagnose or stage osteoarthritis using your history, exam, and imaging.

Does the COMT gene really affect joint pain?

Research associates the lower-activity COMT Val158Met variant with heightened pain sensitivity, which helps explain why cartilage loss and reported pain often diverge. COMT does not cause osteoarthritis; it influences how strongly the nervous system registers pain signals, making it one useful piece of a fuller genetic picture.

What can I do if my genetics raise my risk?

Focus on the modifiable factors: maintain a healthy weight, build strength around vulnerable joints, prioritize protein, vitamin D, and omega-3s, and address injuries early. These habits interact with genes like MMP3 and IL1B. Share your genetic context with a qualified provider to personalize the plan.

Curious how your own DNA shapes these pathways? Take the Precision Peptide Genetic Test to see pathway-level genetic context you can bring to your next provider conversation — know your biology instead of guessing.

This article is part of the PlexusDx Education Hub. Browse all Genetics & Joint Health education

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.